InsiderClue
← All stocks

Arcus Biosciences, Inc.

RCUS Scheduled selling only
CIK 0001724521 #1577 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$84.81K
$0.00 on a plan · $84.81K straight out of an exercise
Sold at will
$0.00
0 of 1 sales
Net
−$84.81K
$0.00 against sales at will

By person

16 insiders · 1 transaction
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Azoy Alexander
Chief Accounting Officer
—
$84.81K (1) scheduled
−$84.81K
39,581
0.0311%
$1.19M
+69.1%
GILEAD SCIENCES, INC. entity
10% owner
—
—
—
31,424,760
24.68%
$942.74M
+4.5%
ROSEN TERRY J
Chief Executive Officer
—
—
—
2,236,409
1.76%
$67.09M
+6.4%
Jaen Juan C.
President
—
—
—
1,199,252
0.9418%
$35.98M
−21.2%
Jarrett Jennifer
Chief Operating Officer
—
—
—
224,024
0.1759%
$6.72M
+16.8%
Tang Carolyn C.
General Counsel
—
—
—
184,607
0.1450%
$5.54M
+60.1%
Markus Richard
Chief Medical Officer
—
—
—
89,647
0.0704%
$2.69M
—
Nuyten Dimitry SA
Chief Medical Officer
—
—
—
87,518
0.0687%
$2.63M
−8.2%
Goeltz II Robert C.
Chief Financial Officer
—
—
—
84,161
0.0661%
$2.52M
+14.0%
Lacey David L.
Director
—
—
—
76,652
0.0602%
$2.30M
+33.0%
PERLMAN ANDREW J
Director
—
—
—
48,325
0.0380%
$1.45M
+64.8%
FALBERG KATHRYN E
Director
—
—
—
44,300
0.0348%
$1.33M
+75.1%
Machado Patrick
Director
—
—
—
44,300
0.0348%
$1.33M
+75.1%
Ribas Antoni
Director
—
—
—
44,300
0.0348%
$1.33M
+46.0%
Lambert Nicole
Director
—
—
—
43,000
0.0338%
$1.29M
+79.2%
KANEKO YASUNORI
Director
—
—
—
25,700
0.0202%
$771.00K
—

Individual transactions

1
Insider
Date
Role
Action
Shares
Price
Amount
Azoy Alexander
21 Aug 2026
Chief Accounting Officer
Sold after exercise
2,827
$30.00
$84.81K

What was left out

Form 4 filings counted 1
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 1
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 2,827
History held since 19 Mar 2018